Back

C Suite Market Update - May 2014

May 2014

C-level turnover for May 2014 saw healthy increases over last month and especially for CEO’s and CFO’s.  Although overall C –Level turnover remained virtually the same year over year (May 2014 over May 2013), there was a marked increase in CFO turnover (+17% over last year).  Month over month changes included +38% turnover in CEO’s, +48% turnover in CFO’s and overall C-Level changes of +8%. Board of Director changes showed the only decline, -14%.
 
Executive turnover activities break down as follows:

  • CEO changes, +38%   A total of  211 changes with the largest number of changes occurring in energy, drugs and health services. Last month’s changes occurred primarily in energy, drugs and banking.
  • CFO changes,  +48%   A total of 247 changes with the largest number of changes occurring in business services, drugs/biotech and energy. Last month’s changes occurred primarily in drugs/biotech, energy, banking and metals/mining.
  • Board of Directors,  -14%   A total of 428 changes with the largest number of changes occurring in drugs/biotech, energy and business services. Last month’s changes occurred primarily in drugs/biotech, chemicals and banking.
  • Overall C suite, +8%.  A total of 1513 changes with the largest number of changes occurring in drugs/biotech, business services and banking. Last month’s changes occurred in drugs/biotech, banking and energy.

Overall, the turnover trend looks positive despite some industry and market fluctuations. Of interest is the increase in turnover this past month in the business services sector, with banking changes being minimal. The significant turnover in CEO and CFO roles indicates a very positive market for executives in these areas to make a change.